Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers

NCT02828865 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT02828865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02828865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
May 27, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, metastatic liver cancers